Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA2260075
Max Phase: Preclinical
Molecular Formula: C43H40N4O10S2
Molecular Weight: 836.95
Molecule Type: Small molecule
Associated Items:
ID: ALA2260075
Max Phase: Preclinical
Molecular Formula: C43H40N4O10S2
Molecular Weight: 836.95
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: COc1ccc2nc(NCCC(=O)Oc3ccc(/C=C/C(=O)CC(=O)/C=C/c4ccc(OC(=O)CCNc5nc6ccc(OC)cc6s5)c(OC)c4)cc3OC)sc2c1
Standard InChI: InChI=1S/C43H40N4O10S2/c1-52-30-11-13-32-38(24-30)58-42(46-32)44-19-17-40(50)56-34-15-7-26(21-36(34)54-3)5-9-28(48)23-29(49)10-6-27-8-16-35(37(22-27)55-4)57-41(51)18-20-45-43-47-33-14-12-31(53-2)25-39(33)59-43/h5-16,21-22,24-25H,17-20,23H2,1-4H3,(H,44,46)(H,45,47)/b9-5+,10-6+
Standard InChI Key: DTLAZNNEIXEKKD-NXZHAISVSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 836.95 | Molecular Weight (Monoisotopic): 836.2186 | AlogP: 8.01 | #Rotatable Bonds: 20 |
Polar Surface Area: 173.50 | Molecular Species: NEUTRAL | HBA: 16 | HBD: 2 |
#RO5 Violations: 3 | HBA (Lipinski): 14 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 9.63 | CX Basic pKa: 3.79 | CX LogP: 8.05 | CX LogD: 8.05 |
Aromatic Rings: 6 | Heavy Atoms: 59 | QED Weighted: 0.03 | Np Likeness Score: -0.41 |
1. Al-Wabli RI, AboulWafa OM, Youssef KM. (2012) Synthesis of curcumin and ethylcurcumin bioconjugates as potential antitumor agents, 21 (6): [10.1007/s00044-011-9587-3] |
Source(1):